You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 18, 2021

Tilleke & Gibbins Lawyers Speak on Data Privacy and Protection in Relation to COVID-19

On November 17, Tilleke & Gibbins conducted another joint TMT webinar with Clyde & Co. The event provided a multijurisdictional view in a session titled “Data Privacy and Protection in COVID-19 Times.” Lawyers from Tilleke & Gibbins covered the legal and regulatory environments in Thailand and Vietnam, while lawyers from Clyde & Co spoke on Australia, China, and Singapore.

Atthachai Homhuan, director of the regulatory affairs department at Tilleke & Gibbins, explained emergency use authorization of drugs and vaccines in Thailand, as well as data privacy and protection issues related to employers, employees, and vaccinations.

Waewpen Piemwichai, a senior associate in Tilleke & Gibbins corporate and commercial group in Hanoi, followed the Thailand session with a look at the evolving pandemic situation in Vietnam and noted how the processing of COVID-19-related data will change when the draft Decree on Personal Data Protection takes effect.

RELATED INSIGHTS​ 

September 21, 2018
Thailand’s regulatory approach toward the infant nutrition industry would benefit from additional clarity, according to an article published by FoodNavigator-Asia. The article draws on a presentation given by Dr. Atthachai Homhuan and San Chaithiraphant of the Tilleke & Gibbins intellectual property and regulatory affairs teams at the recent Vitafoods Asia 2018 conference, held in Singapore on September 11-12.
September 13, 2018
Tilleke & Gibbins’ Jakarta office has been nominated for two awards at the fifth annual Asian Legal Business  Indonesia Law Awards. Our team has received a nomination for Intellectual Property Firm of the Year, and has also been recognized for our outstanding reputation in the Indonesian life sciences industry with a nomination for Medical and Healthcare Law Firm of the Year—one of just three firms nominated for this prestigious award.